<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.cerebrospinalfluidresearch.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Cerebrospinal Fluid Research - Most accessed articles</title>
        <link>http://www.cerebrospinalfluidresearch.com</link>
        <description>The most accessed research articles published by Cerebrospinal Fluid Research</description>
        <dc:date>2010-02-26T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.cerebrospinalfluidresearch.com/content/5/1/10" />
                                <rdf:li rdf:resource="http://www.cerebrospinalfluidresearch.com/content/7/1/5" />
                                <rdf:li rdf:resource="http://www.cerebrospinalfluidresearch.com/content/1/1/3" />
                                <rdf:li rdf:resource="http://www.cerebrospinalfluidresearch.com/content/7/1/6" />
                                <rdf:li rdf:resource="http://www.cerebrospinalfluidresearch.com/content/7/1/1" />
                                <rdf:li rdf:resource="http://www.cerebrospinalfluidresearch.com/content/7/1/4" />
                                <rdf:li rdf:resource="http://www.cerebrospinalfluidresearch.com/content/6/1/1" />
                                <rdf:li rdf:resource="http://www.cerebrospinalfluidresearch.com/content/7/1/3" />
                                <rdf:li rdf:resource="http://www.cerebrospinalfluidresearch.com/content/6/1/17" />
                                <rdf:li rdf:resource="http://www.cerebrospinalfluidresearch.com/content/7/1/2" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.cerebrospinalfluidresearch.com/content/5/1/10">
        <title>Multiplicity of cerebrospinal fluid functions: new challenges in health and disease</title>
        <description>This review integrates eight aspects of cerebrospinal fluid (CSF) circulatory dynamics: formation rate, pressure, flow, volume, turnover rate, composition, recycling and reabsorption. Novel ways to modulate CSF formation emanate from recent analyses of choroid plexus transcription factors (E2F5), ion transporters (NaHCO3 cotransport), transport enzymes (isoforms of carbonic anhydrase), aquaporin 1 regulation, and plasticity of receptors for fluid-regulating neuropeptides. A greater appreciation of CSF pressure (CSFP) is being generated by fresh insights on peptidergic regulatory servomechanisms, the role of dysfunctional ependyma and circumventricular organs in causing congenital hydrocephalus, and the clinical use of algorithms to delineate CSFP waveforms for diagnostic and prognostic utility. Increasing attention focuses on CSF flow: how it impacts cerebral metabolism and hemodynamics, neural stem cell progression in the subventricular zone, and catabolite/peptide clearance from the CNS. The pathophysiological significance of changes in CSF volume is assessed from the respective viewpoints of hemodynamics (choroid plexus blood flow and pulsatility), hydrodynamics (choroidal hypo- and hypersecretion) and neuroendocrine factors (i.e., coordinated regulation by atrial natriuretic peptide, arginine vasopressin and basic fibroblast growth factor). In aging, normal pressure hydrocephalus and Alzheimer&apos;s disease, the expanding CSF space reduces the CSF turnover rate, thus compromising the CSF sink action to clear harmful metabolites (e.g., amyloid) from the CNS. Dwindling CSF dynamics greatly harms the interstitial environment of neurons. Accordingly the altered CSF composition in neurodegenerative diseases and senescence, because of adverse effects on neural processes and cognition, needs more effective clinical management. CSF recycling between subarachnoid space, brain and ventricles promotes interstitial fluid (ISF) convection with both trophic and excretory benefits. Finally, CSF reabsorption via multiple pathways (olfactory and spinal arachnoidal bulk flow) is likely complemented by fluid clearance across capillary walls (aquaporin 4) and arachnoid villi when CSFP and fluid retention are markedly elevated. A model is presented that links CSF and ISF homeostasis to coordinated fluxes of water and solutes at both the blood-CSF and blood-brain transport interfaces.Outline1 Overview2 CSF formation2.1 Transcription factors2.2 Ion transporters2.3 Enzymes that modulate transport2.4 Aquaporins or water channels2.5 Receptors for neuropeptides3 CSF pressure3.1 Servomechanism regulatory hypothesis3.2 Ontogeny of CSF pressure generation3.3 Congenital hydrocephalus and periventricular regions3.4 Brain response to elevated CSF pressure3.5 Advances in measuring CSF waveforms4 CSF flow4.1 CSF flow and brain metabolism4.2 Flow effects on fetal germinal matrix4.3 Decreasing CSF flow in aging CNS4.4 Refinement of non-invasive flow measurements5 CSF volume5.1 Hemodynamic factors5.2 Hydrodynamic factors5.3 Neuroendocrine factors6 CSF turnover rate6.1 Adverse effect of ventriculomegaly6.2 Attenuated CSF sink action7 CSF composition7.1 Kidney-like action of CP-CSF system7.2 Altered CSF biochemistry in aging and disease7.3 Importance of clearance transport7.4 Therapeutic manipulation of composition8 CSF recycling in relation to ISF dynamics8.1 CSF exchange with brain interstitium8.2 Components of ISF movement in brain8.3 Compromised ISF/CSF dynamics and amyloid retention9 CSF reabsorption9.1 Arachnoidal outflow resistance9.2 Arachnoid villi vs. olfactory drainage routes9.3 Fluid reabsorption along spinal nerves9.4 Reabsorption across capillary aquaporin channels10 Developing translationally effective models for restoring CSF balance11 Conclusion</description>
        <link>http://www.cerebrospinalfluidresearch.com/content/5/1/10</link>
                <dc:creator>Conrad Johanson</dc:creator>
                <dc:creator>John Duncan</dc:creator>
                <dc:creator>Petra Klinge</dc:creator>
                <dc:creator>Thomas Brinker</dc:creator>
                <dc:creator>Edward Stopa</dc:creator>
                <dc:creator>Gerald Silverberg</dc:creator>
                <dc:source>Cerebrospinal Fluid Research 2008, 5:10</dc:source>
        <dc:date>2008-05-14T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-8454-5-10</dc:identifier>
        <prism:publicationName>Cerebrospinal Fluid Research</prism:publicationName>
        <prism:issn>1743-8454</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2008-05-14T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cerebrospinalfluidresearch.com/content/7/1/5">
        <title>Cerebrospinal fluid pulse pressure amplitude during lumbar infusion in idiopathic normal pressure hydrocephalus can predict response to shunting</title>
        <description>Background:
We have previously seen that idiopathic normal pressure hydrocephalus (iNPH) patients having elevated intracranial pressure (ICP) pulse amplitude consistently respond to shunt surgery. In this study we explored how the cerebrospinal fluid pressure (CSFP) pulse amplitude determined during lumbar infusion testing, correlates with ICP pulse amplitude determined during over-night ICP monitoring and with response to shunt surgery. Our goal was to establish a more reliable screening procedure for selecting iNPH patients for shunt surgery using lumbar intrathecal infusion.
Methods:
The study population consisted of all iNPH patients undergoing both diagnostic lumbar infusion testing and continuous over-night ICP monitoring during the period 2002-2007. The severity of iNPH was assessed using our NPH grading scale before surgery and 12 months after shunting. The CSFP pulse was characterized from the amplitude of single pressure waves.
Results:
Totally 62 iNPH patients were included, 45 of them underwent shunt surgery, in whom 78% were shunt responders. Among the 45 shunted patients, resistance to CSF outflow (Rout) was elevated (&#8805; 12 mmHg/ml/min) in 44. The ICP pulse amplitude recorded over-night was elevated (i.e. mean ICP wave amplitude &#8805; 4 mmHg) in 68% of patients; 92% of these were shunt responders. In those with elevated overnight ICP pulse amplitude, we found also elevated CSFP pulse amplitude recorded during lumbar infusion testing, both during the opening phase following lumbar puncture and during a standardized period of lumbar infusion (15 ml Ringer over 10 min). The clinical response to shunting after 1 year strongly associated with the over-night ICP pulse amplitude, and also with the pulsatile CSFP during the period of lumbar infusion. Elevated CSFP pulse amplitude during lumbar infusion thus predicted shunt response with sensitivity of 88 and specificity of 60 (positive and negative predictive values of 89 and 60, respectively).
Conclusions:
In iNPH patients, shunt response can be anticipated in 9/10 patients with elevated overnight ICP pulse amplitude, while in only 1/10 with low ICP pulse amplitude. Additionally, the CSFP pulse amplitude during lumbar infusion testing was elevated in patients with elevated over-night ICP pulse amplitude. In particular, measurement of CSFP pulse amplitude during a standardized infusion of 15 ml Ringer over 10 min was useful in predicting response to shunt surgery and can be used as a screening procedure for selection of iNPH patients for shunting.</description>
        <link>http://www.cerebrospinalfluidresearch.com/content/7/1/5</link>
                <dc:creator>Per Eide</dc:creator>
                <dc:creator>Are Brean</dc:creator>
                <dc:source>Cerebrospinal Fluid Research 2010, 7:5</dc:source>
        <dc:date>2010-02-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-8454-7-5</dc:identifier>
        <prism:publicationName>Cerebrospinal Fluid Research</prism:publicationName>
        <prism:issn>1743-8454</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2010-02-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cerebrospinalfluidresearch.com/content/1/1/3">
        <title>Homeostatic capabilities of the choroid plexus epithelium in Alzheimer&apos;s disease</title>
        <description>As the secretory source of vitamins, peptides and hormones for neurons, the choroid plexus (CP) epithelium critically provides substances for brain homeostasis. This distributive process of cerebrospinal fluid (CSF) volume transmission reaches many cellular targets in the CNS. In ageing and ageing-related dementias, the CP-CSF system is less able to regulate brain interstitial fluid. CP primarily generates CSF bulk flow, and so its malfunctioning exacerbates Alzheimers disease (AD). Considerable attention has been devoted to the blood-brain barrier in AD, but more insight is needed on regulatory systems at the human blood-CSF barrier in order to improve epithelial function in severe disease. Using autopsied CP specimens from AD patients, we immunocytochemically examined expression of heat shock proteins (HSP90 and GRP94), fibroblast growth factor receptors (FGFr) and a fluid-regulatory protein (NaK2Cl cotransporter isoform 1 or NKCC1). CP upregulated HSP90, FGFr and NKCC1, even in end-stage AD. These CP adjustments involve growth factors and neuropeptides that help to buffer perturbations in CNS water balance and metabolism. They shed light on CP-CSF system responses to ventriculomegaly and the altered intracranial pressure that occurs in AD and normal pressure hydrocephalus. The ability of injured CP to express key regulatory proteins even at Braak stage V/VI, points to plasticity and function that may be boosted by drug treatment to expedite CSF dynamics. The enhanced expression of human CP &apos;homeostatic proteins&apos; in AD dementia is discussed in relation to brain deficits and pharmacology.</description>
        <link>http://www.cerebrospinalfluidresearch.com/content/1/1/3</link>
                <dc:creator>Conrad Johanson</dc:creator>
                <dc:creator>Paul McMillan</dc:creator>
                <dc:creator>Rosemarie Tavares</dc:creator>
                <dc:creator>Anthony Spangenberger</dc:creator>
                <dc:creator>John Duncan</dc:creator>
                <dc:creator>Gerald Silverberg</dc:creator>
                <dc:creator>Edward Stopa</dc:creator>
                <dc:source>Cerebrospinal Fluid Research 2004, 1:3</dc:source>
        <dc:date>2004-12-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-8454-1-3</dc:identifier>
        <prism:publicationName>Cerebrospinal Fluid Research</prism:publicationName>
        <prism:issn>1743-8454</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2004-12-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cerebrospinalfluidresearch.com/content/7/1/6">
        <title>Microarray-based gene expression profiling and DNA copy number variation analysis of temporal fossa arachnoid cysts</title>
        <description>Background:
Intracranial arachnoid cysts (AC) are membranous sacs filled with CSF-like fluid that are commonly found in the temporal fossa. The majority of ACs are congenital. Typical symptoms are headache, dizziness, and dyscognition. Little is known about genes that contribute to the formation of the cyst membranes.
Methods:
In order to identify differences in gene expression between normal arachnoid membrane (AM) and cyst membrane, we have performed a high-resolution mRNA microarray analysis. In addition we have screened DNA from AC samples for chromosomal duplications or deletions using DNA microarray-based copy number variation analysis.
Results:
The transcriptome consisting of 33096 gene probes showed a near-complete similarity in expression between AC and AM samples. Only nine genes differed in expression between the two tissues: ASGR1, DPEP2, SOX9, SHROOM3, A2BP1, ATP10D, TRIML1, NMU were down regulated, whereas BEND5 was up regulated in the AC samples. Three of the AC samples had unreported human DNA copy number variations, all DNA gains.
Conclusions:
Extending results of previous anatomical studies, the present study has identified a small subset of differentially expressed genes and DNA alterations in arachnoid cysts compared to normal arachnoid membrane.</description>
        <link>http://www.cerebrospinalfluidresearch.com/content/7/1/6</link>
                <dc:creator>Mads Aarhus</dc:creator>
                <dc:creator>Christian Helland</dc:creator>
                <dc:creator>Morten Lund-Johansen</dc:creator>
                <dc:creator>Knut Wester</dc:creator>
                <dc:creator>Per Knappskog</dc:creator>
                <dc:source>Cerebrospinal Fluid Research 2010, 7:6</dc:source>
        <dc:date>2010-02-26T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-8454-7-6</dc:identifier>
        <prism:publicationName>Cerebrospinal Fluid Research</prism:publicationName>
        <prism:issn>1743-8454</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2010-02-26T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cerebrospinalfluidresearch.com/content/7/1/1">
        <title>The regulation of brain states by neuroactive substances distributed via the cerebrospinal fluid; a review </title>
        <description>The cerebrospinal fluid (CSF) system provides nutrients to and removes waste products from the brain. Recent findings suggest, however, that in addition, the CSF contains message molecules in the form of actively released neuroactive substances. The concentrations of these vary between locations, suggesting they are important for the changes in brain activity that underlie different brain states, and induce different sensory input and behavioral output relationships.The cranial CSF displays a rapid caudally-directed ventricular flow followed by a slower rostrally-directed subarachnoid flow (mainly towards the cribriform plate and from there into the nasal lymphatics). Thus, many brain areas are exposed to and can be influenced by substances contained in the CSF. In this review we discuss the production and flow of the CSF, including the mechanisms involved in the regulation of its composition. In addition, the available evidence for the release of neuropeptides and other neuroactive substances into the CSF is reviewed, with particular attention to the selective effects of these on distant downstream receptive brain areas. As a conclusion we suggest that (1) the flowing CSF is involved in more than just nutrient and waste control, but is also used as a broadcasting system consisting of coordinated messages to a variety of nearby and distant brain areas; (2) this special form of volume transmission underlies changes in behavioral states.</description>
        <link>http://www.cerebrospinalfluidresearch.com/content/7/1/1</link>
                <dc:creator>Jan Veening</dc:creator>
                <dc:creator>Henk Barendregt</dc:creator>
                <dc:source>Cerebrospinal Fluid Research 2010, 7:1</dc:source>
        <dc:date>2010-01-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-8454-7-1</dc:identifier>
        <prism:publicationName>Cerebrospinal Fluid Research</prism:publicationName>
        <prism:issn>1743-8454</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2010-01-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cerebrospinalfluidresearch.com/content/7/1/4">
        <title>Elevated CSF outflow resistance associated with impaired lymphatic CSF absorption in a rat model of kaolin-induced communicating hydrocephalus</title>
        <description>Background:
We recently reported a lymphatic cerebrospinal fluid (CSF) absorption deficit in a kaolin model of communicating hydrocephalus in rats with ventricular expansion correlating negatively with the magnitude of the impediment to lymphatic function. However, it is possible that CSF drainage was not significantly altered if absorption at other sites compensated for the lymphatic defect. The purpose of this study was to investigate the impact of the lymphatic absorption deficit on global CSF absorption (CSF outflow resistance).
Methods:
Kaolin was injected into the basal cisterns of Sprague Dawley rats. The development of hydrocephalus was assessed using magnetic resonance imaging (MRI). In one group of animals at about 3 weeks after injection, the movement of intraventricularly injected iodinated human serum albumin (125I-HSA) into the olfactory turbinates provided an estimate of CSF transport through the cribriform plate into nasal lymphatics (n = 18). Control animals received saline in place of kaolin (n = 10). In a second group at about 3.5 weeks after kaolin injection, intraventricular pressure was measured continuously during infusion of saline into the spinal subarachnoid space at various flow rates (n = 9). CSF outflow resistance was calculated as the slope of the steady-state pressure versus flow rate. Control animals for this group either received no injections (intact: n = 11) or received saline in place of kaolin (n = 8).
Results:
Compared to saline injected controls, lateral ventricular volume in the kaolin group was significantly greater (0.087 &#177; 0.013 ml, n = 27 versus 0.015 &#177; 0.001 ml, n = 17) and lymphatic function was significantly less (2.14 &#177; 0.72% injected/g, n = 18 versus 6.38 &#177; 0.60% injected/g, n = 10). Additionally, the CSF outflow resistance was significantly greater in the kaolin group (0.46 &#177; 0.04 cm H2O.&#956;L-1.min, n = 9) than in saline injected (0.28 &#177; 0.03 cm H2O.&#956;L-1.min, n = 8) or intact animals (0.18 &#177; 0.03 cm H2O.&#956;L-1.min, n = 11). There was a significant positive correlation between CSF outflow resistance and ventricular volume.
Conclusions:
The data suggest that the impediment to lymphatic CSF absorption in a kaolin-induced model of communicating hydrocephalus has a significant impact on global CSF absorption. A lymphatic CSF absorption deficit would appear to play some role (either direct or indirect) in the pathogenesis of ventriculomegaly.</description>
        <link>http://www.cerebrospinalfluidresearch.com/content/7/1/4</link>
                <dc:creator>Gurjit Nagra</dc:creator>
                <dc:creator>Mark Wagshul</dc:creator>
                <dc:creator>Shams Rashid</dc:creator>
                <dc:creator>Jie Li</dc:creator>
                <dc:creator>J Pat McAllister</dc:creator>
                <dc:creator>Miles Johnston</dc:creator>
                <dc:source>Cerebrospinal Fluid Research 2010, 7:4</dc:source>
        <dc:date>2010-02-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-8454-7-4</dc:identifier>
        <prism:publicationName>Cerebrospinal Fluid Research</prism:publicationName>
        <prism:issn>1743-8454</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2010-02-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cerebrospinalfluidresearch.com/content/6/1/1">
        <title>A review of the current treatment methods for posthaemorrhagic hydrocephalus of infants</title>
        <description>Posthaemorrhagic hydrocephalus (PHH) is a major problem for premature infants, generally requiring lifelong care. It results from small blood clots inducing scarring within CSF channels impeding CSF circulation. Transforming growth factor &#8211; beta is released into CSF and cytokines stimulate deposition of extracellular matrix proteins which potentially obstruct CSF pathways. Prolonged raised pressures and free radical damage incur poor neurodevelopmental outcomes. The most common treatment involves permanent ventricular shunting with all its risks and consequences.This is a review of the current evidence for the treatment and prevention of PHH and shunt dependency. The Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library) and PubMed (from 1966 to August 2008) were searched. Trials using random or quasi-random patient allocation for any intervention were considered in infants less than 12 months old with PHH. Thirteen trials were identified although speculative interventions were also evaluated.The literature confirms that lumbar punctures, diuretic drugs and intraventricular fibrinolytic therapy can have significant adverse effects and fail to prevent shunt dependence, death or disability. There is no evidence that postnatal phenobarbital administration prevents intraventricular haemorrhage (IVH). Subcutaneous reservoirs and external drains have not been tested in randomized controlled trials, but can be useful as a temporising measure. Drainage, irrigation and fibrinolytic therapy as a way of removing blood to inhibit progressive deposition of matrix proteins, permanent hydrocephalus and shunt dependency, are invasive and experimental. Studies of ventriculo-subgaleal shunts show potential as a temporary method of CSF diversion, but have high infection rates.At present no clinical intervention has been shown to reduce shunt surgery in these infants. A ventricular shunt is not advisable in the early phase after PHH. Evidence exists that pre-delivery corticosteroid therapy reduces mortality and IVH and there may be trends towards reduced disability in the short term. There is also evidence that postnatal indomethacin reduces IVH but with no effect on mortality or disability. Overall, there is still no definitive algorithm for the treatment of PHH or prevention of shunt dependence. New therapeutic approaches in neonatal care, including those aimed at pre-empting PHH, offer the best hope of improving neurodevelopmental outcomes.</description>
        <link>http://www.cerebrospinalfluidresearch.com/content/6/1/1</link>
                <dc:creator>David Shooman</dc:creator>
                <dc:creator>Howard Portess</dc:creator>
                <dc:creator>Owen Sparrow</dc:creator>
                <dc:source>Cerebrospinal Fluid Research 2009, 6:1</dc:source>
        <dc:date>2009-01-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-8454-6-1</dc:identifier>
        <prism:publicationName>Cerebrospinal Fluid Research</prism:publicationName>
        <prism:issn>1743-8454</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2009-01-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cerebrospinalfluidresearch.com/content/7/1/3">
        <title>Cerebrospinal fluid sodium rhythms</title>
        <description>Background:
Cerebrospinal fluid (CSF) sodium levels have been reported to rise during episodic migraine. Since migraine frequently starts in early morning or late afternoon, we hypothesized that natural sodium chronobiology may predispose susceptible persons when extracellular CSF sodium increases. Since no mammalian brain sodium rhythms are known, we designed a study of healthy humans to test if cation rhythms exist in CSF.
Methods:
Lumbar CSF was collected every ten minutes at 0.1 mL/min for 24 h from six healthy participants. CSF sodium and potassium concentrations were measured by ion chromatography, total protein by fluorescent spectrometry, and osmolarity by freezing point depression. We analyzed cation and protein distributions over the 24 h period and spectral and permutation tests to identify significant rhythms. We applied the False Discovery Rate method to adjust significance levels for multiple tests and Spearman correlations to compare sodium fluctuations with potassium, protein, and osmolarity.
Results:
The distribution of sodium varied much more than potassium, and there were statistically significant rhythms at 12 and 1.65 h periods. Curve fitting to the average time course of the mean sodium of all six subjects revealed the lowest sodium levels at 03.20 h and highest at 08.00 h, a second nadir at 09.50 h and a second peak at 18.10 h. Sodium levels were not correlated with potassium or protein concentration, or with osmolarity.
Conclusion:
These CSF rhythms are the first reports of sodium chronobiology in the human nervous system. The results are consistent with our hypothesis that rising levels of extracellular sodium may contribute to the timing of migraine onset. The physiological importance of sodium in the nervous system suggests that these rhythms may have additional repercussions on ultradian functions.</description>
        <link>http://www.cerebrospinalfluidresearch.com/content/7/1/3</link>
                <dc:creator>Michael Harrington</dc:creator>
                <dc:creator>Ronald Salomon</dc:creator>
                <dc:creator>Janice Pogoda</dc:creator>
                <dc:creator>Elena Oborina</dc:creator>
                <dc:creator>Neil Okey</dc:creator>
                <dc:creator>Benjamin Johnson</dc:creator>
                <dc:creator>Dennis Schmidt</dc:creator>
                <dc:creator>Alfred Fonteh</dc:creator>
                <dc:creator>Nathan Dalleska</dc:creator>
                <dc:source>Cerebrospinal Fluid Research 2010, 7:3</dc:source>
        <dc:date>2010-01-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-8454-7-3</dc:identifier>
        <prism:publicationName>Cerebrospinal Fluid Research</prism:publicationName>
        <prism:issn>1743-8454</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2010-01-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cerebrospinalfluidresearch.com/content/6/1/17">
        <title>The influence of coughing on cerebrospinal fluid pressure in an in vitro syringomyelia model with spinal subarachnoid space stenosis</title>
        <description>Background:
The influence of coughing, on the biomechanical environment in the spinal subarachnoid space (SAS) in the presence of a cerebrospinal fluid flow stenosis, is thought to be an important etiological factor in craniospinal disorders, including syringomyelia (SM), Chiari I malformation, and hydrocephalus. The aim of this study was to investigate SAS and syrinx pressures during simulated coughing using in vitro models and to provide information for the understanding of the craniospinal fluid system dynamics to help develop better computational models.
Methods:
Four in vitro models were constructed to be simplified representations of: 1) non-communicating SM with spinal SAS stenosis; 2) non-communicating SM due to spinal SAS stenosis with a distensible spinal column; 3) non-communicating SM post surgical removal of a spinal SAS stenosis; and 4) a spinal SAS stenosis due to spinal trauma. All of the models had a flexible spinal cord. To simulate coughing conditions, an abrupt CSF pressure pulse (~ 5 ms) was imposed at the caudal end of the spinal SAS by a computer-controlled pump. Pressure measurements were obtained at 4 cm intervals along the spinal SAS and syrinx using catheter tip transducers.
Results:
Pressure measurements during a simulated cough, showed that removal of the stenosis was a key factor in reducing pressure gradients in the spinal SAS. The presence of a stenosis resulted in a caudocranial pressure drop in the SAS, whereas pressure within the syrinx cavity varied little caudocranially. A stenosis in the SAS caused the syrinx to balloon outward at the rostral end and be compressed at the caudal end. A &gt;90% SAS stenosis did not result in a significant Venturi effect. Increasing compliance of the spinal column reduced forces acting on the spinal cord. The presence of a syrinx in the cord when there was a stenosis in the SAS, reduced pressure forces in the SAS. Longitudinal pressure dissociation acted to suck fluid and tissue caudocranially in the SAS with a stenosis.
Conclusions:
Pressures in the spinal SAS during a simulated cough in vitro had similar peak, transmural, and longitudinal pressures to in vivo measurements reported in the literature. The pressure wave velocities and pressure gradients during coughing (longitudinal pressure dissociation and transmural pressure) were impacted by alterations in geometry, compliance, and the presence of a syrinx and/or stenosis.</description>
        <link>http://www.cerebrospinalfluidresearch.com/content/6/1/17</link>
                <dc:creator>Bryn Martin</dc:creator>
                <dc:creator>Francis Loth</dc:creator>
                <dc:source>Cerebrospinal Fluid Research 2009, 6:17</dc:source>
        <dc:date>2009-12-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-8454-6-17</dc:identifier>
        <prism:publicationName>Cerebrospinal Fluid Research</prism:publicationName>
        <prism:issn>1743-8454</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>17</prism:startingPage>
        <prism:publicationDate>2009-12-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cerebrospinalfluidresearch.com/content/7/1/2">
        <title>Expression and functional activity of nucleoside transporters in human choroid plexus</title>
        <description>Background:
Human equilibrative nucleoside transporters (hENTs) 1-3 and human concentrative nucleoside transporters (hCNTs) 1-3 in the human choroid plexus (hCP) play a role in the homeostasis of adenosine and other naturally occurring nucleosides in the brain; in addition, hENT1, hENT2 and hCNT3 mediate membrane transport of nucleoside reverse transcriptase inhibitors that could be used to treat HIV infection, 3&apos;-azido-3&apos;-deoxythymidine, 2&apos;3&apos;-dideoxycytidine and 2&apos;3&apos;-dideoxyinosine. This study aimed to explore the expression levels and functional activities of hENTs 1-3 and hCNTs 1-3 in human choroid plexus.
Methods:
Freshly-isolated pieces of lateral ventricle hCP, removed for various clinical reasons during neurosurgery, were obtained under Local Ethics Committee approval. Quantification of mRNAs that encoded hENTs and hCNTs was performed by the hydrolysis probes-based reverse transcription real time-polymerase chain reaction (RT-qPCR); for each gene of interest and for 18 S ribosomal RNA, which was an endogenous control, the efficiency of PCR reaction (E) and the quantification cycle (Cq) were calculated. The uptake of [3H]inosine by the choroid plexus pieces was investigated to explore the functional activity of hENTs and hCNTs in the hCP.
Results:
RT-qPCR revealed that the mRNA encoding the intracellularly located transporter hENT3 was the most abundant, with E-Cq value being only about 40 fold less that the E-Cq value for 18 S ribosomal RNA; mRNAs encoding hENT1, hENT2 and hCNT3 were much less abundant than mRNA for the hENT3, while mRNAs encoding hCNT1 and hCNT2 were of very low abundance and not detectable. Uptake of [3H]inosine by the CP samples was linear and consisted of an Na+-dependent component, which was probably mediated by hCNT3, and Na+-independent component, mediated by hENTs. The latter component was not sensitive to inhibition by S-(4-nitrobenzyl)-6-thioinosine (NBMPR), when used at a concentration of 0.5 &#956;M, a finding that excluded the involvement of hENT1, but it was very substantially inhibited by 10 &#956;M NBMPR, a finding that suggested the involvement of hENT2 in uptake.
Conclusion:
Transcripts for hENT1-3 and hCNT3 were detected in human CP; mRNA for hENT3, an intracellularly located nucleoside transporter, was the most abundant. Human CP took up radiolabelled inosine by both concentrative and equilibrative processes. Concentrative uptake was probably mediated by hCNT3; the equilibrative uptake was mediated only by hENT2. The hENT1 transport activity was absent, which could suggest either that this protein was absent in the CP cells or that it was confined to the basolateral side of the CP epithelium.</description>
        <link>http://www.cerebrospinalfluidresearch.com/content/7/1/2</link>
                <dc:creator>Zoran Redzic</dc:creator>
                <dc:creator>Slava Malatiali</dc:creator>
                <dc:creator>Danica Grujicic</dc:creator>
                <dc:creator>Aleksandra Isakovic</dc:creator>
                <dc:source>Cerebrospinal Fluid Research 2010, 7:2</dc:source>
        <dc:date>2010-01-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-8454-7-2</dc:identifier>
        <prism:publicationName>Cerebrospinal Fluid Research</prism:publicationName>
        <prism:issn>1743-8454</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2010-01-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
